Search
Popular searches:
Mucor
Yeast
Rhizopus arrhizus
Lichtheimia
Rhizopus
Trichosporon faecale
Please choose case details first for advanced search.
Reset
Risk Factors
Alcoholism
Rheumatic disease/Autoimmune disease
Burn
Cancer (ALL)
Cancer (AML)
Cancer (CLL)
Cancer (CML)
Cancer (Lymphoma)
Cancer Other
Chemotherapy
Chronic liver disease
Chronic pulmonary disease
Chronic renal disease
Corticosteroids
Diabetes mellitus
Hematopoietic stem cell transplantation (HSCT)
HIV/AIDS
ICU
IV drug user
Major surgery
Neutropenia
Premature birth
Solid organ transplantation
Trauma
No risk factor identified
Site of Infection
Biliary system
Blood
Bones
CNS
Deep soft tissues
Eyes
Foreign body
Gastrointestinal tract
Genitourinary tract
Kidneys
Liver
Lungs
Paranasal sinus(es)
Peritoneum
Skin
Spleen
Disseminated
Targeted Therapy
Amphotericin B deoxycholate
Amphotericin B lipid complex
Liposomal amphotericin B
Flucytosine
Fluconazole
Isavuconazole
Itraconazole
Posaconazole
Voriconazole
Anidulafungin
Caspofungin
Micafungin
Final Response
Complete response
Partial response
Stable disease
Deterioration or failure
Usage Distribution Map
Principle Investigator:
Prof. Oliver A. Cornely
, MD, FACP, FIDSA, FAAM, FECMM, Cologne, Germany
Project Manager:
Dr. Danila Seidel
, PhD, FECMM, Cologne, Germany
Coordinating physician:
Dr. Jannik Stemler
, MD, FECMM, MD, Cologne, Germany
Epidemiology & Statistics:
Nico Bekaan
, MD, Cologne, Germany
Imprint
|
Privacy